As previously shown, VISTA can either act as a receptor expressed on T cells that binds to a ligand and activates the TCR-related downstream inhibitory pathways to exert an inhibitory effect on T cells or as a ligand (e.g. expressed on tumor cells) that acts in conjunction with an unknown receptor (14). Here, VSIR is linked to neoplasm.